Kopran Limited (BOM:524280)

India flag India · Delayed Price · Currency is INR
120.40
-2.55 (-2.07%)
At close: Mar 9, 2026
-31.67%
Market Cap 5.81B
Revenue (ttm) 6.20B
Net Income (ttm) 165.43M
Shares Out 48.29M
EPS (ttm) 3.42
PE Ratio 35.25
Forward PE n/a
Dividend 3.00 (2.44%)
Ex-Dividend Date Sep 4, 2025
Volume 25,792
Average Volume 8,165
Open 122.20
Previous Close 122.95
Day's Range 115.75 - 122.95
52-Week Range 119.60 - 214.65
Beta 0.29
RSI 31.69
Earnings Date May 15, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 1,024
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524280
Full Company Profile

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.

Financial Statements

News

There is no news available yet.